Switch to:
More From Other Websites
U.S. Drugmakers Facing First Wave Of Biosimilars Apr 01 2015
Our Take on the First Quarter Apr 01 2015
Cramer: Problem feeding all investing decisions now Mar 31 2015
How Actavis and Allergan Merger May Boost Branded Business Mar 31 2015
Biogen's Biosimilar Version of Remicade Under EU Review - Analyst Blog Mar 31 2015
Zimmer-Biomet Deal Gets European Commission's Approval - Analyst Blog Mar 31 2015
Zimmer Unveils External Fixation System, Expands in Trauma - Analyst Blog Mar 30 2015
Busiest Day for Health-Care Deals Is Set to Spawn More: Real M&A Mar 30 2015
Hospira's INFLECTRA™ (Infliximab) Now Available in Canada Mar 30 2015
Hospira's INFLECTRA™ (Infliximab) Now Available in Canada Mar 30 2015
Hospira's INFLECTRA™ (Infliximab) Now Available in Canada Mar 30 2015
11:30 am Hospira announces the availability of INFLECTRA (infliximab) in Canada, the country's first... Mar 30 2015
Hospira Presents Data on Retacrit, an Epogen Biosimilar - Analyst Blog Mar 30 2015
The Best Performing Stocks of 2015 in the S&P 500 Mar 29 2015
Hyperion Could Be Next Pharma Target With Orphan Drugs: Real M&A Mar 28 2015
The Pharmacyclics–AbbVie Merger: What Are the Details? Mar 28 2015
Neogen Lags Q3 Earnings & Revenue Estimates, Stock Down - Analyst Blog Mar 27 2015
Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And... Mar 27 2015
Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And... Mar 27 2015
Biogen downgrade, Pfizer rises Mar 23 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK